Clinical Trials Logo
  1. Home
  2. Cutaneous Lupus Erythematosus
  3. NCT03134222

Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

Cutaneous Lupus Erythematosus Clinical Trial

Official title:
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib and GS-9876 in Female Subjects With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

Clinical Trial Summary

The primary objective of this study is to evaluate the efficacy of filgotinib and lanraplenib (formerly GS-9876) in females with moderately-to-severely active cutaneous lupus erythematosus (CLE).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03134222
Study type Interventional
Source Gilead Sciences
Contact
Status Completed
Phase Phase 2
Start date May 24, 2017
Completion date December 18, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT01776190 - Low-dose UVA1 Radiation in Cutaneous Lupus Patients N/A
Completed NCT00420173 - Interdisciplinary Study Group of Lupus Erythematosus (ISGLE) N/A
Terminated NCT04809623 - Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) Phase 1
Completed NCT01300208 - To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus Phase 2
Terminated NCT01470313 - A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus Phase 1
Completed NCT01146444 - Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) N/A
Completed NCT01629784 - Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus N/A
Completed NCT00470912 - Sunscreen RV 2457C in Photoinduced CLE Phase 3
Completed NCT01841619 - IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus Phase 0
Completed NCT00523588 - Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser Phase 2
Recruiting NCT06411106 - Deep Phenotyping of Cutaneous Lupus Erythematosus N/A
Not yet recruiting NCT06015737 - A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus Phase 3
Terminated NCT01498406 - Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus Phase 2
Completed NCT04647708 - Study of M5049 in CLE and SLE Participants Phase 1
Completed NCT03817424 - A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis Phase 1
Active, not recruiting NCT03260166 - Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus Phase 2
Completed NCT00317681 - Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE) Phase 2
Completed NCT04781816 - Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus Phase 2